Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy

被引：0
|
作者：
Yoshiaki Nakamura
Takeharu Yamanaka
Keisho Chin
Haruhiko Cho
Hitoshi Katai
Masanori Terashima
Kazunari Misawa
Motohiro Hirao
Kazuhiro Yoshida
Eiji Oki
Mitsuru Sasako
Yasunori Emi
Hideaki Bando
Yoshiyuki Kawashima
Tetsu Fukunaga
Masahiro Gotoh
Takako Ishibashi
Kohei Shitara
机构：
[1] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[2] Yokohama City University,Department of Biostatistics
[3] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[4] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[5] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Surgery
[6] National Cancer Center Hospital,Division of Gastric Surgery
[7] Shizuoka Cancer Center,Division of Gastric Surgery
[8] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[9] National Hospital Organization Osaka National Hospital,Department of Surgery
[10] Gifu University,Department of Surgical Oncology, Graduate School of Medicine
[11] Kyushu University Hospital,Department of Surgery and Science, Graduate School of Medical Sciences
[12] Hyogo College of Medicine,Department of Surgery
[13] Saiseikai Fukuoka General Hospital,Department of Surgery
[14] Saitama Cancer Center,Department of Gastroenterological Surgery
[15] St. Marianna University School of Medicine,Department of Gastroenterological and General Surgery
[16] Osaka Medical College,Cancer Chemotherapy Center
[17] Yokohama City University Hospital,Center for Novel and Exploratory Clinical Trials
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
Capecitabine Plus Oxaliplatin (CAPOX); Survival Outcomes; Gastric Cancer; pStage; Histological Type;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：465 / 472
页数：7
相关论文
共 50 条
  • [21] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    Yamamoto, Masaaki
    Omori, Takeshi
    Shinno, Naoki
    Hara, Hisashi
    Mukai, Yosuke
    Sugase, Takahito
    Takeoka, Tomohira
    Mikamori, Manabu
    Kanemura, Takashi
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
  • [22] S-1 plus oxaliplatin versus capecitabine plus oxaliplatin chemotherapy in the treatment of patients with metastatic colorectal cancer: A meta-analysis
    Lalusis, J.
    Pandy, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S94 - S94
  • [23] Adjuvant nab-paclitaxel plus S-1 versus oxaliplatin plus capecitabine after curative D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase 3 open-label, randomized controlled trial
    Yu Pengfei
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Ying, Jieer
    Chen, Ping
    Wei, Yunhai
    Wu, Yingjie
    Yan, Zhilong
    Xu, Hongtao
    Zhang, Xiaojing
    Li, Yong
    Zheng, Zhichao
    Chen, Zhiheng
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 386 - 386
  • [24] Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer
    Yang, Lin
    Yang, Yi
    Qin, Qiong
    Zhou, Aiping
    Zhao, Jianjun
    Wang, Jinwan
    Shu, Chang
    Yuan, Xinghua
    Hu, Songnian
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 93 - 98
  • [25] Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis
    Jeong, Sang-Ho
    Kim, Rock Bum
    Oh, Sung Eun
    An, Ji Yeong
    Seo, Kyung Won
    Min, Jae-Seok
    CANCERS, 2022, 14 (16)
  • [26] CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients
    Yang, Lin
    Zou, Shanshan
    Shu, Chang
    Song, Yan
    Sun, Yong-Kun
    Zhang, Wen
    Zhou, Aiping
    Yuan, Xinghua
    Yang, Yi
    Hu, Songnian
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (04) : 255 - 262
  • [27] Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for gastric cancer
    Wang, G. X.
    Yang, L.
    Song, Y.
    Zhang, W.
    Yong, K. Sun
    Zhou, A.
    Huang, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 25 - 25
  • [28] Adjuvant nab-paclitaxel plus S-1 versus capecitabine plus oxaliplatin for patients with stage III gastric adenocarcinoma after D2 dissection: A multicenter, open-label, randomized phase 3 study
    Yu, Pengfei
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Ying, Jieer
    Chen, Ping
    Wei, Yunhai
    Wu, Yingjie
    Zhang, Xiaojing
    Yan, Zhilong
    Chen, Zhiheng
    Xu, Hongtao
    Li, Yong
    Zheng, Zhichao
    Xu, Nong
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Takeshi Tsuji
    Jin Matsuyama
    Shohei Iijima
    Hiroshi Imamura
    Kentaro Inoue
    Kenji Kobayashi
    Yukinori Kurokawa
    Toshio Shimokawa
    Toshimasa Tsujinaka
    Hiroshi Furukawa
    Gastric Cancer, 2014, 17 : 348 - 353
  • [30] FIVE-YEAR OUTCOMES OF A PHASE II STUDY OF ADJUVANT CHEMOTHERAPY WITH S-1 PLUS DOCETAXEL FOR STAGE III GASTRIC CANCER AFTER CURATIVE D2 GASTRECTOMY
    Shigeyuki, Tamura
    Kazumasa, Fujitani
    Yutaka, Kimura
    Takeshi, Tsuji
    Shohei, Iijima
    Jin, Matsuyama
    Hiroshi, Imamura
    Kentarou, Inoue
    Kenji, Kobayashi
    Yukinori, Kurokawa
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    ANNALS OF ONCOLOGY, 2014, 25 : 40 - 40
12345